Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing
Authors
Keywords
-
Journal
Nature Communications
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-06-30
DOI
10.1038/s41467-022-30896-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Generation of hypoimmunogenic T cells from genetically engineered allogeneic human induced pluripotent stem cells
- (2021) Bo Wang et al. Nature Biomedical Engineering
- Engineering of NK activating receptor ligands enhances immune compatibility of MHC-I−/− iPSC-derived β cells for cell therapy of type 1 diabetes
- (2020) R. Chimienti et al. CYTOTHERAPY
- Genetic Ablation of HLA Class I, Class II, and the T-cell Receptor Enables Allogeneic T Cells to Be Used for Adoptive T-cell Therapy
- (2020) Yuki Kagoya et al. Cancer Immunology Research
- The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
- (2020) Yuanyuan Zhang et al. Cellular & Molecular Immunology
- Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma
- (2020) Paolo Strati et al. HAEMATOLOGICA
- Engineered off-the-shelf therapeutic T cells resist host immune rejection
- (2020) Feiyan Mo et al. NATURE BIOTECHNOLOGY
- Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma
- (2020) Kitsada Wudhikarn et al. Blood Cancer Journal
- Detection and Modulation of DNA Translocations During Multi-Gene Genome Editing in T Cells
- (2020) Anne Bothmer et al. CRISPR Journal
- Strategies for Genetically Engineering Hypoimmunogenic Universal Pluripotent Stem Cells
- (2020) Wei Zhao et al. iScience
- Engineering tolerance toward allogeneic CAR-T cells by regulation of MHC surface expression with Human Herpes Virus-8 proteins
- (2020) Xiaomei Wang et al. MOLECULAR THERAPY
- Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors
- (2020) Anthony K. Park et al. Science Translational Medicine
- Abrogation of HLA surface expression using CRISPR/Cas9 genome editing: a step toward universal T cell therapy
- (2020) Jeewon Lee et al. Scientific Reports
- Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients
- (2019) Tobias Deuse et al. NATURE BIOTECHNOLOGY
- A review of bispecific antibodies and antibody constructs in oncology and clinical challenges
- (2019) Frans V. Suurs et al. PHARMACOLOGY & THERAPEUTICS
- Generation of hypoimmunogenic human pluripotent stem cells
- (2019) Xiao Han et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A platform for extracellular interactome discovery identifies novel functional binding partners for the immune receptors B7-H3/CD276 and PVR/CD155
- (2019) Bushra Husain et al. MOLECULAR & CELLULAR PROTEOMICS
- Senescent cells evade immune clearance via HLA-E-mediated NK and CD8+ T cell inhibition
- (2019) Branca I. Pereira et al. Nature Communications
- Kinetics of Immune Reconstitution after CD19 CAR-T Cell Therapy in ALL Patients
- (2019) Ying Wang et al. BLOOD
- HLA-matched and HLA-haploidentical allogeneic CD19-directed chimeric antigen receptor T-cell infusions are feasible in relapsed or refractory B-cell acute lymphoblastic leukemia before hematopoietic stem cell transplantation
- (2019) Xin Jin et al. LEUKEMIA
- Repurposing endogenous immune pathways to tailor and control chimeric antigen receptor T cell functionality
- (2019) Mohit Sachdeva et al. Nature Communications
- Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors
- (2019) Beau R. Webber et al. Nature Communications
- Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells
- (2018) Quirin Hammer et al. NATURE IMMUNOLOGY
- Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
- (2018) Jae H. Park et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Pharmacology of T Cell Therapies
- (2018) Michael C. Milone et al. Molecular Therapy-Methods & Clinical Development
- Reprogramming human T cell function and specificity with non-viral genome targeting
- (2018) Theodore L. Roth et al. NATURE
- Distinct HLA-E Peptide Complexes Modify Antibody-Driven Effector Functions of Adaptive NK Cells
- (2018) Alexander Rölle et al. Cell Reports
- HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells
- (2017) Germán G Gornalusse et al. NATURE BIOTECHNOLOGY
- CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
- (2017) Terry J Fry et al. NATURE MEDICINE
- Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells
- (2017) Waseem Qasim et al. Science Translational Medicine
- Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8+ T cells
- (2017) Michel Enamorado et al. Nature Communications
- Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia
- (2017) Anne-Sophie Chretien et al. Frontiers in Immunology
- Long-term maintenance of peripheral blood derived human NK cells in a novel human IL-15- transgenic NOG mouse
- (2017) Ikumi Katano et al. Scientific Reports
- CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date
- (2016) Jae H. Park et al. BLOOD
- CRISPR-Cas9-mediated multiplex gene editing in CAR-T cells
- (2016) Xiaojuan Liu et al. CELL RESEARCH
- Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition
- (2016) Jiangtao Ren et al. CLINICAL CANCER RESEARCH
- Roles of CD48 in regulating immunity and tolerance
- (2016) Shannon L. McArdel et al. CLINICAL IMMUNOLOGY
- Recognition and Regulation of T Cells by NK Cells
- (2016) Katharina Pallmer et al. Frontiers in Immunology
- Multiplex Genome-Edited T-cell Manufacturing Platform for “Off-the-Shelf” Adoptive T-cell Immunotherapies
- (2015) Laurent Poirot et al. CANCER RESEARCH
- A Multidrug-resistant Engineered CAR T Cell for Allogeneic Combination Immunotherapy
- (2015) Julien Valton et al. MOLECULAR THERAPY
- The pharmacology of second-generation chimeric antigen receptors
- (2015) Sjoukje J. C. van der Stegen et al. NATURE REVIEWS DRUG DISCOVERY
- An Effective Approach to Prevent Immune Rejection of Human ESC-Derived Allografts
- (2014) Zhili Rong et al. Cell Stem Cell
- RNAi-mediated TCR Knockdown Prevents Autoimmunity in Mice Caused by Mixed TCR Dimers Following TCR Gene Transfer
- (2014) Mario Bunse et al. MOLECULAR THERAPY
- Targeted sequencing by proximity ligation for comprehensive variant detection and local haplotyping
- (2014) Paula J P de Vree et al. NATURE BIOTECHNOLOGY
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
- (2014) M. L. Davila et al. Science Translational Medicine
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation